Care Delivery

This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.

Ascension, FTC reach deal as $3.9B acquisition of Amsurg is finalized
The buyout, announced last summer, drew the attention of federal regulators at the Federal Trade Commission, concerned that competition for ambulatory surgery services would be stifled by the merger. To appease the agency, Ascension has agreed to divest from some centers previously owned by Amsurg.
Top 6 worries about healthcare AI among clinicians and patients in 2026
AI is now as much a part of U.S. healthcare as any other technology category in wide use across the sector. However, like no other technology, its role is “being actively shaped, not passively adopted” by clinicians and patients alike.
Connection uncovered between liability protections and downsizing decisions—in nursing homes, at least
When nursing homes lose their fear of getting sued for substandard care quality, they tend to make do with fewer caregivers, a new study reveals.
FDA highlights recall of certain Impella introducer kits after 3 injuries
This latest recall was put in place due to an increased risk of blood clots developing during use. Only a small number of hospitals are affected.
Medical societies respond after Trump administration questioned necessity of certain procedures
A recent OIG report suggested vascular surgeons, interventional cardiologists and interventional radiologists may be performing medically unnecessary procedures in office-based labs. Now, some of the leading medical societies from those fields have provided additional context.

Hospital understaffing complaints dog big Northeastern state

Healthcare regulators in the country’s fourth most populous state are getting barraged with complaints about hospital understaffing.

congressional hearing on artificial intelligence

Industry Watcher’s Digest

Buzzworthy developments of the past few days.

How to tap QMS methodologies for speeding AI adoptions

It may hold that applying established people/process/technology principles can help hospitals move AI from experimental research settings to regulated clinical practice.

The Medtronic Symplicity Spyral Renal Denervation system uses a catheter that curls in the renal artery to place radiofrequency electrodes against the vessel wall to ablate the nerves that control vasodilation, so the artery can be propped in the fully open position.

First US patient treated with Medtronic’s FDA-approved renal denervation system

Interventional cardiologist David Kandzari, MD, performed the procedure just days after the device received full FDA approval.

‘We should halt this practice’: Common hormone treatment for donated hearts may be harmful

"This practice has been adopted by multiple organ-procurement organizations and is used on thousands of organ donors each year, without ever having been rigorously studied," one researcher said.

US life expectancy rising from COVID downturn

The COVID-19 pandemic shaved 2.4 years off U.S. life expectancy, and the population has yet to fully recover from the setback.

semaglutide wegovy Novo Nordisk major adverse cardiovascular events

New formula could mean diabetes and weight loss drugs such as semaglutide are only needed every 4 months

GLP-1 agonists are often taken as daily or weekly injections. A new delivery system could help make it so those same drugs are only required three times per year.

Cardiawave Valvosoft non-invasive ultrasound therapy

Cardiawave’s non-invasive ultrasound therapy impresses cardiologists early on—could it be an alternative to SAVR, TAVR?

While TAVR and SAVR are reliable treatments for calcific aortic stenosis, some patients are not considered for those procedures due to severe comorbidities or a limited life expectancy. This is where the investigational Valvosoft device from Cardiawave enters the equation.

Care Delivery

Ascension, FTC reach deal as $3.9B acquisition of Amsurg is finalized

Top 6 worries about healthcare AI among clinicians and patients in 2026

Connection uncovered between liability protections and downsizing decisions—in nursing homes, at least

FDA highlights recall of certain Impella introducer kits after 3 injuries

Medical societies respond after Trump administration questioned necessity of certain procedures